1-5 of 5
Bryone J. Kuss, PhD, BMBS, FRCPA, FRACP
Close
Sort by
Journal Articles

Clinical and Biological Indicators of Duvelisib Efficacy in CLL from the Phase 3 DUO TM Study

Jennifer R. Brown, MD PhD, Ian W. Flinn, MD PhD, Matthew S. Davids, MD, Peter Hillmen, MB ChB, PhD FRCP, FRCPath, Marco Montillo, MD, Zsolt Nagy, MD PhD, Julio Delgado, MD, Bryone J. Kuss, PhD BMBS, FRCPA, FRACP, Constantine S. Tam, MBBS (Hons), MD FRACP, FRCPA, Ulrich Jaeger, MD, Paolo Ghia, MD PhD, Stephan Stilgenbauer, Carol Moreno, MD PhD, NgocDiep Le, MD PhD, Stephanie Lustgarten, PhD, Kam Sprott, PhD, Jonathan A. Pachter, PhD, David T. Weaver, PhD, Florence Cymbalista, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1856.
https://doi.org/10.1182/blood-2018-99-114251
Published: 2018
Journal Articles

Somatic MDC1 Mutation in Putative Pre-Leukaemic Stem Cell of a Biclonal Case of Chronic Lymphocytic Leukaemia

Anya K Hotinski, BSc, BMBS, FRACP, FRCPA, Karen M Lower, BSc (Hons), PhD GradCertEd (HighEd), Bryone J. Kuss, PhD BMBS, FRCPA, FRACP
Journal: Blood
Blood (2018) 132 (Supplement 1): 5534.
https://doi.org/10.1182/blood-2018-99-115704
Published: 2018
Journal Articles

Randomized Trial in Unfit, Elderly Chronic Lymphocytic Leukemia (CLL) Patients with Comorbidities of Dose-Reduced Oral Fludarabine and Cyclophosphamide Plus Obinutuzumab (FC+G) Versus Chlorambucil Plus Obinutuzumab (Cbl+G) As Front-Line Therapy

Stephen P. Mulligan, PhD FRACP, FRCPA, MBBS, Jane A. Freeman, BA, FRACP, FRCPA, MBBS, MPhil, MSc, Xavier Badoux, MBBS, AB, FRACP, FRCPA, Richard Eek, MBCHB, Gavin Cull, MB, BS, DM, FRACP, FRCPA, Naomi J. Mackinlay, MB BS, FRACP, FRCPA, Nicholas E. Murphy, FRCPA, MBBS, FRACP, Duncan P. Carradice, MBBS, FRCPA, FRACP, Ann C. Solterbeck, BSc(hons) MSc PhDAStat, Oliver Giles Best, PhD BSc, Constantine S. Tam, MBBS (Hons), MD FRACP, FRCPA, Bryone J. Kuss, PhD BMBS, FRCPA, FRACP
Journal: Blood
Blood (2018) 132 (Supplement 1): 3144.
https://doi.org/10.1182/blood-2018-99-116287
Published: 2018
Journal Articles

Chronic Lymphocytic Leukaemia Relies on Lipid Scavenging and Synthesis As an Energy Source

Lauren A Thurgood, PhD, Lara Escane, BMedSci, BSci (Hons), Christie A Bader, BSci (Hons), PhD, Karen M Lower, BSc (Hons), PhD GradCertEd (HighEd), Doug A Brooks, BSci, BSci (Hons), PhD, Bryone J. Kuss, PhD, BMBS, FRCPA, FRACP
Journal: Blood
Blood (2018) 132 (Supplement 1): 3117.
https://doi.org/10.1182/blood-2018-99-120241
Published: 2018
Journal Articles

The Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL: Updated Results from the DUO Crossover Extension Study

Matthew S. Davids, MD, Bryone J. Kuss, PhD BMBS, FRCPA, FRACP, Peter Hillmen, MB ChB, PhD FRCP, FRCPath, Marco Montillo, MD, James Essell, MD, Nicole Lamanna, MD, Zsolt Nagy, MD PhD, Constantine S. Tam, MBBS (Hons), MD FRACP, FRCPA, Stephan Stilgenbauer, Paolo Ghia, MD PhD, Julio Delgado, MD, NgocDiep Le, MD PhD, Stephanie Lustgarten, PhD, David T. Weaver, PhD, Ulrich Jaeger, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3140.
https://doi.org/10.1182/blood-2018-99-117521
Published: 2018